NRC Health reports results for the quarter ended June 30 - Earnings Summary
NRC Health reports results for the quarter ended June 30 - Earnings Summary
NRC Health NRC.OQ reported quarterly adjusted earnings of 31 cents per share for the quarter ended June 30. The lone analyst forecast for the quarter was for earnings of 14 cents per share.
Revenue was $35.39 million; analysts expected $34.90 million.
NRC Health's reported EPS for the quarter was a loss of 15 cents.
The company reported a quarterly loss of $3.28 million.
NRC Health shares had fallen by 1.4% this quarter and gained 13.3% so far this year.
FORECAST CHANGES
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advertising & marketing peer group is also "buy"
Wall Street's median 12-month price target for NRC Health is $23.00, about 2.9% above its last closing price of $22.34
This summary was machine generated from LSEG data July 28 at 11:13 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.14 | 0.31 | Beat |
Recent news on NRC Health
See all newsNRC Health expected to post earnings of 21 cents a share - Earnings Preview
Brief: NRC Health - On Aug 7, Shane Harrison, CFO Of NRC Health, Tenders Resignation
NRC Health reports results for the quarter ended June 30 - Earnings Summary
NRC Health Q2 revenue rises on the back of product innovation
Brief: National Research Q2 Adjusted EPS USD 0.31